Results 61 to 70 of about 1,222 (132)

Programmable Macrophage Vesicle Based Bionic Self‐Adjuvanting Vaccine for Immunization against Monkeypox Virus

Advanced Science, Volume 12, Issue 1, January 9, 2025.
The monkeypox‐specific bionic vaccine (AM@AEvs‐PB) is consists of IMV antigens (A29L, M1R), the EEV antigen (B6R), and MPV‐preactivated macrophagederived vesicles. AM@AEvs‐PB can induce enhanced innate immune responses, promote cross‐presentation of antigens to dendritic cells (DCs), and elicit robust adaptive immune responses, realizing immunization ...
Weiqiang Lin, Chenguang Shen, Mengjun Li, Shengchao Ma, Chenxin Liu, Jialin Huang, Zuning Ren, Yuechao Yang, Minghai Zhao, Qiulin Xie, Shuang Guo, Wei Wang, Kaiyuan Wang, Qiang Ma, Yideng Jiang, Judun Zheng, Yuhui Liao   +16 more
wiley   +1 more source

The Growing Mpox Infections by Clade I Variant in African Countries Is a Public Health Emergency of International Concern: A Narrative Review

Health Science Reports, Volume 8, Issue 1, January 2025.
ABSTRACT Background and Aim In 2022, the monkeypox (mpox) outbreak was declared a public health emergency of international concern. The emergence of a new strain in the Democratic Republic of the Congo and its identification with neighboring countries led to the declaration of a public health emergency in 2024.
Taslima Jamal Urmi, Md. Rabiul Islam
wiley   +1 more source

RETRACTED ARTICLE: An overview on mRNA-based vaccines to prevent monkeypox infection

Journal of Nanobiotechnology
The human monkeypox virus (Mpox) is classified as a member of the Poxviridae family and belongs to the Orthopoxvirus genus. Mpox possesses double-stranded DNA, and there are two known genetic clades: those originating in West Africa and the Congo Basin ...
Mohammad Natami, Amirsasan Gorgzadeh, Arsalan Gholipour, Seyedeh Narges Fatemi, Nima Firouzeh, Maryam Zokaei, Saad Hasan Mohammed Ali, Hadis Kheradjoo, Somayeh Sedighi, Omid Gholizadeh, Shaylan Kalavi   +10 more
doaj   +1 more source

Short-Lived Neutralizing Antibody Responses to Monkeypox Virus in Smallpox Vaccine–Naive Persons after JYNNEOS Vaccination

Emerging Infectious Diseases
JYNNEOS, a third-generation smallpox vaccine, is integral to monkeypox virus (MPXV) control efforts, but the durability of this modified vaccinia Ankara–Bavarian Nordic (MVA-BN) vaccine’s effectiveness is undefined.
Kara Phipps, Jennifer Yates, Jessica Pettit, Sean Bialosuknia, Danielle Hunt, Alan P. DuPuis, Anne Payne, William Lee, Kathleen A. McDonough   +8 more
doaj   +1 more source

Monkeypox and Pregnancy: Protecting Two Lives

Journal of the Pakistan Medical Association
Dear Madam, Monkeypox virus (MPXV), an emerging zoonotic disease, is becoming a global threat, with an unrelenting surge of cases all over Europe and America, prompting WHO to declare it an international concern on July 23rd, 2023 (1).
Maryum Imran, Javeria Kamran
doaj   +1 more source

mRNA Vaccine Against Mpox: A Promising Healthcare Strategy

Animal Research and One Health, Volume 3, Issue 2, Page 177-180, May 2025.
Mohammad Shah Alam, Md. Arman Sharif, Md. Aminul Islam, M. Nazmul Hoque   +3 more
wiley   +1 more source

Mpox unveiled: Global epidemiology, treatment advances, and prevention strategies

One Health
Mpox (monkeypox), caused by the monkeypox virus (MPXV), is a zoonotic disease from the Poxviridae family, closely related to smallpox. It presents with high fever, rash, and pustules, with human-to-human transmission first reported in the Democratic ...
Anna Bogacka, Agnieszka Wroczynska, Weronika Rymer, Paweł Grzesiowski, Ravi Kant, Maciej Grzybek, Miłosz Parczewski   +6 more
doaj   +1 more source

Plant-derived molecules in monkeypox management: insight and alternative therapeutic strategies

Beni-Suef University Journal of Basic and Applied Sciences
The WHO and CDC recently declared monkeypox virus (MPXV) a zoonotic disease known as monkeypox (Mpox) a Public Health Emergency of International Concern. According to the CDC, no treatment is specifically approved for Mpox infections.
Martin Ndayambaje, Emmanuel Munyeshyaka, Olive Dieumerci, Thierry Habyarimana, Pacifique Ndishimye, Abdallah Naya, Mounia Oudghiri   +6 more
doaj   +1 more source

Monkeypox: A Comprehensive Review of Virology, Epidemiology, Transmission, Diagnosis, Prevention, Treatment, and Artificial Intelligence Applications

Archives of Academic Emergency Medicine
Monkeypox (Mpox), an uncommon zoonotic Orthopoxvirus, is commonly manifested by blisters on the skin and has a mortality rate of approximately 0-10%. Approximately two decades after the cessation of global smallpox vaccination, the number of confirmed ...
Erfan Rahmani, Ziba Bayat, Mehrdad Farrokhi, Shiva Karimian, Reza Zahedpasha, Hamed Sabzehie, Sepehr Ramezani Poor, Parisa Jafari Khouzani, Solmaz Aminpour, Mohammad Karami, Omid Afsharjahanshahi, Maryam Sharifi, Behnaz Dalvandi, Reza Dalvandi, Amirhossein Esfahani, Maryam Alaei, Mahtab Mirbolouk, Fateme Moradi, Amitis Nozari, Seyed Mohammad Shahab Mirabedini, Mahrokh Janmohamadi, Sara Moghimi, Farzaneh Nikfarjam, Faezeh Jalayer Sarnaghy, Amirhossein Mirbolook, Mohammad Pirouzan, Mozhdeh Mohammadi Virsoudi, Atousa Moghadam Fard, Mehdi Nikandishnobar, Hossein Boustani Hezarani, Mohammadreza Fadavighafari, Masoud Farrokhi   +31 more
doaj   +1 more source

The global patent landscape of emerging infectious disease monkeypox

BMC Infectious Diseases
Background Monkeypox is an emerging infectious disease with confirmed cases and deaths in several parts of the world. In light of this crisis, this study aims to analyze the global knowledge pattern of monkeypox-related patents and explore current trends
Yuanqi Cai, Xiaoming Zhang, Kuixing Zhang, Jingbo Liang, Pingping Wang, Jinyu Cong, Xin Xu, Mengyao li, Kunmeng Liu, Benzheng Wei   +9 more
doaj   +1 more source